Everspin Partners with Teledyne HiRel to Expand MRAM in Aerospace and Defense

What happened

Everspin Technologies announced a strategic partnership with Teledyne HiRel Semiconductors to accelerate MRAM adoption in aerospace and defense applications, combining Everspin's MRAM portfolio with Teledyne's high-reliability semiconductor supply chain. The partnership adds another credible distribution and integration channel, but it does not immediately resolve the core financial execution risks highlighted in the DeepValue report, which flagged that Q1'26 revenue was 96% point-in-time with 90% distributor concentration and no measurable defense milestone recognition. The company still faces cash obligations from the Microchip foundry agreement before first shipments in 2H27, litigation-driven G&A increases, and dilution risk from share-based compensation. While the collaboration may eventually lead to design wins and program revenue, there is no auditable evidence yet that defense subcontracts like the $40 million Amentum deal are converting into contract assets or billings. Investors should view this as a positive signal but not a near-term catalyst until financial statements show tangible progress.

Implication

Investors should monitor whether this collaboration generates task orders, design wins, or milestone acceptances that translate into contract assets/liabilities and revenue in Q2/Q3'26 filings. Without such evidence, the partnership remains a headline that does not address the company's high valuation, channel concentration, or cash burn concerns. The DeepValue report's attractive entry price of $18 and trim above $32 remain appropriate, and any position should be sized cautiously given insider selling and legal overhang. The next 3–6 months will be critical: if Amentum program accounting and xSPI mix shift fail to materialize by Q4'26, the defense narrative loses credibility and valuation compression becomes likely.

Thesis delta

The partnership adds a credible channel but does not alter the core thesis: defense contracts must become visible revenue, and xSPI density ramp must materialize. No shift in rating; the WAIT stands, with emphasis on Q3/Q4 filings for Amentum accounting signals and 2H26 xSPI volume.